A research that was conducted in the Netherlands on Cannabidiol (CBD), a compound found in Marijuana, concluded that CBD is an effective medical treatment that does not result in psychopathic effect or cause “high”.
- The same research was recently reviewed and according to results provided; Cannabidiol (CBD) has the medicinal potential of reducing chances of patients getting “stoned” or having psychotic experiences like in the case of other medicines prescribed by doctors which have fewer side effects. The research review also shows that CBD can be used to treat Schizophrenia, a mental disorder associated with delusions and hallucinations.
- Reports from the government health institutions show that Schizophrenia affects close to 3.6 million Americans. The disease mostly starts in childhood and its lethal effects are usually felt by people of between 15 to 26 years old. History of Schizophrenia shows that it tends to kill more males than females. This is because the average female affected by Schizophrenia may only get the symptoms after many years. Most females are said to experience symptoms at the age of 30.
Antipsychotic impact of Cannabidiol (CBD)
The findings regarding the antipsychotic effects of CBD were strongly backed by Lillian Kloft, a forensic psychologist who performed a review of previous research on effects of the Cannabidiol (CBD). As part of her review, she examined previous clinical studies and experiments that were aimed at investigating CBD as a potential Schizophrenia treatment. She mostly based her review studies on; human experiments, brain imaging, infection studies and clinical studies. All this pointed CBD towards one direction which is; it is the best alternative available antipsychotic treatment.